Paulo Vidal Campregher

Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells

Harlan Robins, Paulo Vidal Campregher, Santosh K. Srivastava et al. · Blood · 2009 · 1.2K citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Overlap and Effective Size of the Human CD8 ⁺ T Cell Receptor Repertoire

Harlan Robins, S. K. Srivastava, Paulo Vidal Campregher et al. · Science Translational Medicine · 2010 · 421 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +16

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD

Afonso Celso Vigorito, Paulo Vidal Campregher, Barry E. Storer et al. · Blood · 2009 · 262 citations · Full text

Medicine, Internal Medicine, Health Assessment +3

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Peter Horak, Malachi Griffith, Arpad Danos et al. · Genetics in Medicine · 2022 · 239 citations · Full text

Medicine, Genetics, Oncology +17

HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib

Sai‐Hong Ignatius Ou, Alexa B. Schrock, Eduard V. Bocharov et al. · Journal of Thoracic Oncology · 2016 · 112 citations · Full text

Medicine, Genetics, Oncology +17